Skip to content
lifestyle.serversfree.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Mineralys Therapeutics, Inc.
Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference
August 26, 2026
Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
August 13, 2026
Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 11, 2026
Mineralys Therapeutics to Announce Second Quarter 2026 Financial Results and Host Conference Call on Tuesday, August 11, 2026
August 5, 2026
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
July 27, 2026
Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)
June 14, 2026
Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
June 8, 2026
Mineralys Therapeutics to Present Late-Breaking Data on Lorundrostat at The Endocrine Society Annual Meeting (ENDO 2026)
June 8, 2026
Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing
June 3, 2026
Mineralys Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock
June 3, 2026
1
2
3
Next Page
→